News

January 31, 2019

Radiation therapy, the use of high-energy particles or waves, such as x-rays, gamma rays, electrons, or protons, has long been used to treat cancer. From as early as the 20th Century, physicians have given regular doses of radiation to greatly improve the patient’s cha...

January 14, 2019

10 companies were selected under the healthcare category and 4 were from Israel, including Alpha Tau Medical.

January 3, 2019

#CancerBuster

Now going into clinical trials for specific types of cancer, Alpha Tau’s technology shows potential for treating any solid tumor.
 

By Brian Blum  JANUARY 3, 2019, 8:00 AM

Alpha Tau is working toward commercializing its alpha radiation therapy technolog...

December 20, 2018

Alpha Tau Medical today announced that it will present at Biotech Showcase™ 2019, to be held January 7–9, during the JP Morgan Healthcare week at the Hilton San Francisco Union Square.

Alpha TAU's CEO, Uzi Sofer, will present as follows:

Date: Tuesday, January...

An Israeli medical technology company is set to begin testing its new radiation cancer therapy in leading medical centers in Italy. The Alpha DaRT (Dіffusіng Alpha-emіtters Radіatіon Therapy) device delivers high-precision alpha radiation that is released when radioact...

November 7, 2018

Trials will investigate the efficacy of its breakthrough cancer treatment, Alpha DaRT, in Squamous Cell Carcinoma (SCC) of the Skin, and Cutaneous and Mucosal malignant Neoplasia (CMN)

TEL AVIV, Israel--(BUSINESS WIRE)--Alpha Tau Medical, developer of a breakthrough alp...

November 5, 2018

The Jewish New Year has now begun, providing us with a great opportunity to kick-off our quarterly Alpha Tau newsletter.

This last year has seen fantastic progress. The significant operational, regulatory and clinical advancement was summarised by additional funding o...

Cancer is the most devastating chronic disease affecting humankind. More than 1 out of 3 people in the United States will have cancer during their lifetimes, of which 30% of them will die 5 years from diagnosis [i].  As people live longer, the number of new cancer case...

September 5, 2018

Proceeds to accelerate expansion of global clinical research program and establish new production facilities to meet growing demand for the company's breakthrough cancer treatment, Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy).

TEL AVIV, Israel, -- Alpha Tau M...

August 23, 2018

The Massachusetts Radiation Control Program (RCP), in conjunction with the U.S. Nuclear Regulatory Commission (NRC), has approved Alpha Tau Medical’s Alpha DaRT cancer treatment as a Sealed Source and Device (SSD). 

https://www.dotmed.com/news/story/44162 

Granting of th...

Please reload

Categories
Please reload

Sign up